Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald S Go

Showing results (161-170 of 402) with videos related to

Pageof 41
Sort By:
Blood Advances|March 1, 2023
Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysisAshley Aaroe, Razelle Kurzrock, Gaurav Goyal, et al.
Interventional Cardiology (London, England)|April 2, 2025
Novel Diagnosis of Isolated Cardiac Erdheim-Chester Disease by Interatrial Biopsy Using Frozen Section ExaminationJasraj Singh, Newton B Neidert, Jason H Anderson, et al.
Journal of Oncology Practice|November 4, 2017
Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 YearsNarjust Duma, Jesus Vera Aguilera, Jonas Paludo, et al.
British Journal of Haematology|February 26, 2016
Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network StudyJulie E Chang, Thomas Havighurst, KyungMann Kim, et al.
JCO Oncology Practice|May 26, 2022
Economic Cost and Sustainability of Oral Therapies in Precision OncologyAakash P Desai, Caleb J Scheckel, Leah C Soderberg, et al.
Annals of Hematology|January 15, 2008
Circulating endothelial cells in patients with chronic lymphocytic leukemiaRonald S Go, Dean A Jobe, Krista E Asp, et al.
Cancer|December 15, 2005
Clinical trial accrual among new cancer patients at a community-based cancer centerRonald S Go, Kathleen A Frisby, Jennifer A Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2023
Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans CellsAishwarya Ravindran, Surendra Dasari, Gordon J Ruan, et al.
European Journal of Haematology|April 16, 2024
C3+ and C3- warm autoimmune hemolytic anemias: A comparison of clinical characteristics and treatment outcomesJordan Nunnelee, Jithma Prasad Abeykoon, Aneel A Ashrani, et al.
American Journal of Hematology|October 18, 2021
A population-based study of outcomes in polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the United States from 2001 to 2015: Comparison with data from a Mayo Clinic single institutional seriesCaleb J Smith, John W Thomas, Gordon Ruan, et al.
Pageof 41

Showing results (161-170 of 402) with videos related to

Sort By:
Pageof 41
Blood Advances|March 1, 2023
Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysisAshley Aaroe, Razelle Kurzrock, Gaurav Goyal, et al.
Interventional Cardiology (London, England)|April 2, 2025
Novel Diagnosis of Isolated Cardiac Erdheim-Chester Disease by Interatrial Biopsy Using Frozen Section ExaminationJasraj Singh, Newton B Neidert, Jason H Anderson, et al.
Journal of Oncology Practice|November 4, 2017
Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 YearsNarjust Duma, Jesus Vera Aguilera, Jonas Paludo, et al.
British Journal of Haematology|February 26, 2016
Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network StudyJulie E Chang, Thomas Havighurst, KyungMann Kim, et al.
JCO Oncology Practice|May 26, 2022
Economic Cost and Sustainability of Oral Therapies in Precision OncologyAakash P Desai, Caleb J Scheckel, Leah C Soderberg, et al.
Annals of Hematology|January 15, 2008
Circulating endothelial cells in patients with chronic lymphocytic leukemiaRonald S Go, Dean A Jobe, Krista E Asp, et al.
Cancer|December 15, 2005
Clinical trial accrual among new cancer patients at a community-based cancer centerRonald S Go, Kathleen A Frisby, Jennifer A Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2023
Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans CellsAishwarya Ravindran, Surendra Dasari, Gordon J Ruan, et al.
European Journal of Haematology|April 16, 2024
C3+ and C3- warm autoimmune hemolytic anemias: A comparison of clinical characteristics and treatment outcomesJordan Nunnelee, Jithma Prasad Abeykoon, Aneel A Ashrani, et al.
American Journal of Hematology|October 18, 2021
A population-based study of outcomes in polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the United States from 2001 to 2015: Comparison with data from a Mayo Clinic single institutional seriesCaleb J Smith, John W Thomas, Gordon Ruan, et al.
Pageof 41